<img alt="" height="1" width="1" />AGI slashed its losses in 2009 after giving up on bowel drugIrish Independent... (€7.75m) last year from $18.2m (€13.3m) in 2008 after it canned development of a drug intended to treat diarrhoea-predominant irritable-bowel syndrome. ...<nobr></nobr> |